GLIMY MV1 TAB
Rs 134 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
GLIMY MV1 TAB
Glimy MV 1 Tablet combines Glimepiride, Metformin, and Voglibose to manage type 2 diabetes mellitus effectively. Glimepiride enhances insulin secretion from the pancreas, Metformin decreases glucose production in the liver and improves insulin sensitivity, while Voglibose slows the digestion and absorption of carbohydrates, aiding in better blood glucose control. Typically taken once daily with meals, this combination helps maintain optimal blood glucose levels. Common side effects include nausea, diarrhea, abdominal pain, and hypoglycemia. Regular monitoring and adherence to a prescribed diet and exercise plan are essential for effective diabetes management.
Product Highlights and Usage:
Active Ingredients: Contains Glimepiride 1 mg, Metformin 500 mg, and Voglibose 0.2 mg. Benefits: Manages type 2 diabetes mellitus when diet, exercise, and single-agent or second-line therapy with two drugs are insufficient to control blood sugar. Usage: Taken orally once daily with meals, as prescribed by a physician. Mechanism: Glimepiride stimulates insulin secretion, Metformin reduces glucose production in the liver, and Voglibose slows carbohydrate digestion and absorption. Safety: Not suitable for individuals with severe kidney or liver disease, type 1 diabetes, or during pregnancy and breastfeeding; consult a doctor before use.
How it works:
GLIMY MV 1 TABLET is used to manage type 2 diabetes mellitus. Glimepiride lowers blood glucose levels by increasing the amount of insulin released by the pancreas. Metformin works by decreasing glucose production in the liver and reducing glucose absorption in the stomach and intestine. It also helps restore the body’s response to insulin. Voglibose inhibits the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars. This slows down the digestion and absorption of carbohydrates in the small intestine, leading to reduced blood glucose levels in individuals with type 2 diabetes mellitus.
Directions for use:
Take GLIMY MV 1 TABLET as advised by your physician. Swallow the tablet with a glass of water. Do not crush or chew the tablet. Your doctor will determine the correct dose and duration of treatment based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY GLIMY MV 1 TABLET is not recommended for use during pregnancy since it may cause harm to the fetus. Consult your doctor before taking GLIMY MV 1 TABLET. BREASTFEEDING GLIMY MV 1 TABLET is not recommended for use in breastfeeding women since the medicine may pass through breast milk and may cause harm to the nursing child. Consult your doctor before taking GLIMY MV 1 TABLET. DRIVING AND USING MACHINES Do not drive or operate any machines if you experience impaired alertness or reactions (due to hypoglycemia) while taking GLIMY MV 1 TABLET. ALCOHOL Do not consume alcohol while taking GLIMY MV 1 TABLET since it may reduce your blood sugar level KIDNEY GLIMY MV 1 TABLET is not recommended in patients with severe renal failure. It should be used with caution in patients with other kidney diseases. Consult your doctor before taking the medicine. LIVER GLIMY MV 1 TABLET is not recommended for use in patients with severe liver disease. It should be used with caution in patients with other liver diseases. Consult your doctor before taking the medicine. ALLERGY Do not take GLIMY MV 1 TABLET if you are allergic to glimepiride, metformin, voglibose, other sulfonylureas/sulphonamides, and/or any other ingredients of this medicine. LUNGS GLIMY MV 1 TABLET is not recommended for use in patients with lung problems such as acute or chronic respiratory failure. Consult your doctor before taking GLIMY MV 1 TABLET. HEART DISEASE GLIMY MV 1 TABLET is not recommended in patients with heart problems such as acute or chronic cardiac failure or recent myocardial infarction. Consult your doctor before taking GLIMY MV 1 TABLET. USE IN PEDIATRICS GLIMY MV 1 TABLET is not recommended for use in children and adolescents (aged below 18 years) since the safety and effectiveness of the medicine are not established. Consult your doctor before taking GLIMY MV 1 TABLET. USE IN GERIATRICS GLIMY MV 1 TABLET should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before taking GLIMY MV 1 TABLET.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$